Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction

Therapy with epidermal growth factor receptor (EGFR) inhibitors is inevitably accompanied by the phenomena of dermatological toxicity. Being, on the one hand, a favorable prognostic factor for the effectiveness of anticancer therapy, these adverse events are one of the most frequent indications for...

Full description

Bibliographic Details
Main Authors: A. V. Michenko, L. S. Kruglova, E. A. Shatokhina, I. B. Kononenko, A. S. Polonskaya, D. V. Romanov
Format: Article
Language:Russian
Published: ABV-press 2021-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/504